Evidence map›Paper›PMID 34035243›Full record

ArticleNature communications2021

Health improvement framework for actionable treatment planning using a surrogate Bayesian model.

Kazuki Nakamura, Ryosuke Kojima, Eiichiro Uchino, Koh Ono, Motoko Yanagita, Koichi Murashita, Ken Itoh, Shigeyuki Nakaji, Yasushi Okuno

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Recent developments in machine learning modeling methods for hypertension treatment.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  4. Adopting artificial intelligence in cardiovascular medicine: a scoping review.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kazuki NakamuraResearch and Business Development Department, Kyowa Hakko Bio Co., Ltd., Tokyo, Japan.ORCID http://orcid.org/0000-0002-6322-762X
Ryosuke KojimaDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-1095-8864
Eiichiro UchinoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-3148-0858
Koh OnoDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-4163-980X
Motoko YanagitaDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-0339-9008
Koichi MurashitaCenter of Innovation Research Initiatives Organization, Hirosaki University, Hirosaki, Japan.
Ken ItohDepartment of Stress Response Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID http://orcid.org/0000-0002-5518-0729
Shigeyuki NakajiDepartment of Social Health, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID http://orcid.org/0000-0001-8445-8606
Yasushi OkunoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan. okuno.yasushi.4c@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0003-3596-4208
Kyoto University · JPHirosaki University · JPKyowa Kirin (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical decision-making regarding treatments based on personal characteristics leads to effective health improvements. Machine learning (ML) has been the primary concern of diagnosis support according to comprehensive patient information. A prominent issue is the development of objective treatment processes in clinical situations. This study proposes a framework to plan treatment processes in a data-driven manner. A key point of the framework is the evaluation of the actionability for personal health improvements by using a surrogate Bayesian model in addition to a high-performance nonlinear ML model. We first evaluate the framework from the viewpoint of its methodology using a synthetic dataset. Subsequently, the framework is applied to an actual health checkup dataset comprising data from 3132 participants, to lower systolic blood pressure and risk of chronic kidney disease at the individual level. We confirm that the computed treatment processes are actionable and consistent with clinical knowledge for improving these values. We also show that the improvement processes presented by the framework can be clinically informative. These results demonstrate that our framework can contribute toward decision-making in the medical field, providing clinicians with deeper insights.

Indexed as

Bayes TheoremMachine LearningAlgorithmsClinical Decision-MakingHealth PromotionHumansHypertensionModels, TheoreticalRenal Insufficiency, ChronicReproducibility of Results

Identifiers

PMID34035243
PMCPMC8149666
OpenAlexW3165555433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.